PD-1 is highly expressed by tumour infiltrating lymphocytes (TILs) from many cancers, while PD-1 ligands, in particular PD-L1, are commonly upregulated on the tumour cell surface from many different human tumours and on myeloid cells in the tumour microenvironment. This evidence concerns the gene CD274 and neoplasm.